Efthymios Deliargyris's Net Worth

-$48.1 Thousand

Estimate Recalculated Apr 4, 2024 08:50PM EST

Who is Efthymios Deliargyris?

Efthymios Deliargyris does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PLx Pharma Inc., and Cytosorbents Corp.

SEC CIK

Efthymios Deliargyris's CIK is 0001751617

Past Insider Trading and Trends

2023 was Efthymios Deliargyris's most active year for acquiring shares with 5 total transactions. Efthymios Deliargyris's most active month to acquire stocks was the month of July. 2021 saw Efthymios Deliargyris paying a total of $359,600.00 for 103,250 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PLx Pharma Inc. No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 20
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Mar 14
Form 4
—
0
—
—
0
Aug 29
Form 3
—
0
—
—
0
No matching records found

Cytosorbents Corp (CTSO) Snapshot price: $0.98

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.51%
61K
—
—
409.43K
Apr 2
Form 4
—
0
—
—
0
Mar 29
Form 4
+6.92%
22.56K
$1.33
$30,000.81
348.43K
Dec 13
Form 4
+19.88%
55K
—
—
331.65K
Jul 7
Form 4
+26.43%
107K
—
—
511.77K
Aug 10
Form 4
+27.97%
40K
$8.99
$359,600.00
183K
Apr 12
Form 4
∞
140K
—
—
140K
Apr 12
Form 3
—
0
—
—
0
No matching records found